Tatyanah Farsh
Clinical Research Coordinator
HDF Comprehensive Cancer Ctr
School of Medicine

Publications (3)

Top publication keywords:
Drug Resistance, NeoplasmLysosomesSignal TransductionVesicular Transport ProteinsAndrogen Receptor AntagonistsTranscriptomeProstatic Neoplasms, Castration-ResistantReceptors, Granulocyte-Macrophage Colony-Stimulating FactorPhagocytosisReceptors, AndrogenExocytosisMacrophagesCoculture TechniquesReceptors, SomatostatinAutophagy-Related Proteins

• Exploitable mechanisms of antibody and CAR mediated macrophage cytotoxicity.
  Nature communications 2025 Liu T, Zhang M, Farsh T, Li H, Kishishita A, Barpanda A, Leung SG, Zhu J, Jung H, Hua JT, Zhu X, Kim AB, Goo YA, Son M, Kim J, Subramanian A, Sjöström M, Fuh KC, Chapman JS, Carnevale J, Gilbert LA, …
• Genome-wide CRISPR screens identify PTGES3 as a novel AR modulator.
  bioRxiv : the preprint server for biology 2025 Li H, Melnyk JE, Fu BXH, Shrestha R, Zhang M, Sjöström M, Feng S, Anderson JA, Han W, Chesner LN, Shin HJ, Farsh T, Suarez HJ, Nath S, Chou J, Das R, Egusa EA, Zhu J, Winters A, Maheshwari A, Hua JT, …
• Genomic and transcriptomic features of androgen receptor signaling inhibitor resistance in metastatic castration-resistant prostate cancer.
  The Journal of clinical investigation 2024 Zhu X, Farsh T, Vis D, Yu I, Li H, Liu T, Sjöström M, Shrestha R, Kneppers J, Severson T, Zhang M, Lundberg A, Moreno Rodriguez T, Weinstein AS, Foye A, Mehra N, Aggarwal RR, Bergman AM, Small EJ, …